Addressing Brain Metabolic Connectivity in Treatment-resistant Schizophrenia: a Novel Graph Theory-driven Application of F-FDG-PET with Antipsychotic Dose Correction

Overview

Journal Schizophrenia (Heidelb)

Date 2024 Dec 20

PMID 39702476

Authors

Giuseppe De Simone

Felice Iasevoli

Annarita Barone

Valeria Gaudieri

Alberto Cuocolo

Mariateresa Ciccarelli

Sabina Pappata

Andrea de Bartolomeis

Affiliations

Soon will be listed here.

Abstract

Few studies using Positron Emission Tomography with F-fluorodeoxyglucose (F-FDG-PET) have examined the neurobiological basis of antipsychotic resistance in schizophrenia, primarily focusing on metabolic activity, with none investigating connectivity patterns. Here, we aimed to explore differential patterns of glucose metabolism between patients and controls (CTRL) through a graph theory-based approach and network comparison tests. PET scans with F-FDG were obtained by 70 subjects, 26 with treatment-resistant schizophrenia (TRS), 28 patients responsive to antipsychotics (nTRS), and 16 CTRL. Relative brain glucose metabolism maps were processed in the automated anatomical labeling (AAL)-Merged atlas template. Inter-subject connectivity matrices were derived using Gaussian Graphical Models and group networks were compared through permutation testing. A logistic model based on machine-learning was employed to estimate the association between the metabolic signals of brain regions and treatment resistance. To account for the potential influence of antipsychotic medication, we incorporated chlorpromazine equivalents as a covariate in the network analysis during partial correlation calculations. Additionally, the machine-learning analysis employed medication dose-stratified folds. Global reduced connectivity was detected in the nTRS (p-value = 0.008) and TRS groups (p-value = 0.001) compared to CTRL, with prominent alterations localized in the frontal lobe, Default Mode Network, and dorsal dopamine pathway. Disruptions in frontotemporal and striatal-cortical connectivity were detected in TRS but not nTRS patients. After adjusting for antipsychotic doses, alterations in the anterior cingulate, frontal and temporal gyri, hippocampus, and precuneus also emerged. The machine-learning approach demonstrated an accuracy ranging from 0.72 to 0.8 in detecting the TRS condition.

References

Berge D, Carmona S, Salgado P, Rovira M, Bulbena A, Vilarroya O . Limbic activity in antipsychotic naïve first-episode psychotic subjects during facial emotion discrimination. Eur Arch Psychiatry Clin Neurosci. 2013; 264(4):271-83. DOI: 10.1007/s00406-013-0465-5. View

Veronese M, Moro L, Arcolin M, Dipasquale O, Rizzo G, Expert P . Covariance statistics and network analysis of brain PET imaging studies. Sci Rep. 2019; 9(1):2496. PMC: 6385265. DOI: 10.1038/s41598-019-39005-8. View

Bertolino A, Breier A, Callicott J, Adler C, Mattay V, Shapiro M . The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia. Neuropsychopharmacology. 2000; 22(2):125-32. DOI: 10.1016/S0893-133X(99)00096-2. View

Archila-Melendez M, Sorg C, Preibisch C . Modeling the impact of neurovascular coupling impairments on BOLD-based functional connectivity at rest. Neuroimage. 2020; 218:116871. DOI: 10.1016/j.neuroimage.2020.116871. View

Sala A, Caminiti S, Presotto L, Premi E, Pilotto A, Turrone R . Altered brain metabolic connectivity at multiscale level in early Parkinson's disease. Sci Rep. 2017; 7(1):4256. PMC: 5484707. DOI: 10.1038/s41598-017-04102-z. View

Caminiti S, Tettamanti M, Sala A, Presotto L, Iannaccone S, Cappa S . Metabolic connectomics targeting brain pathology in dementia with Lewy bodies. J Cereb Blood Flow Metab. 2016; 37(4):1311-1325. PMC: 5453453. DOI: 10.1177/0271678X16654497. View

Koshiyama D, Miyakoshi M, Tanaka-Koshiyama K, Joshi Y, Molina J, Sprock J . Neurophysiologic Characterization of Resting State Connectivity Abnormalities in Schizophrenia Patients. Front Psychiatry. 2020; 11:608154. PMC: 7729083. DOI: 10.3389/fpsyt.2020.608154. View

Sala A, Lizarraga A, Caminiti S, Calhoun V, Eickhoff S, Habeck C . Brain connectomics: time for a molecular imaging perspective?. Trends Cogn Sci. 2023; 27(4):353-366. PMC: 10432882. DOI: 10.1016/j.tics.2022.11.015. View

Barone A, De Simone G, Ciccarelli M, Buonaguro E, Tomasetti C, Eramo A . A Postsynaptic Density Immediate Early Gene-Based Connectome Analysis of Acute NMDAR Blockade and Reversal Effect of Antipsychotic Administration. Int J Mol Sci. 2023; 24(5). PMC: 10002165. DOI: 10.3390/ijms24054372. View

10.

Desco M, Gispert J, Reig S, Sanz J, Pascau J, Sarramea F . Cerebral metabolic patterns in chronic and recent-onset schizophrenia. Psychiatry Res. 2003; 122(2):125-35. DOI: 10.1016/s0925-4927(02)00124-5. View

11.

Sone D, Young A, Shinagawa S, Tsugawa S, Iwata Y, Tarumi R . Disease Progression Patterns of Brain Morphology in Schizophrenia: More Progressed Stages in Treatment Resistance. Schizophr Bull. 2023; 50(2):393-402. PMC: 10919766. DOI: 10.1093/schbul/sbad164. View

12.

Leem S, Huh I, Park T . Enhanced Permutation Tests via Multiple Pruning. Front Genet. 2020; 11:509. PMC: 7330123. DOI: 10.3389/fgene.2020.00509. View

13.

Nakahara T, Tsugawa S, Noda Y, Ueno F, Honda S, Kinjo M . Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of H-magnetic resonance spectroscopy studies. Mol Psychiatry. 2021; 27(1):744-757. DOI: 10.1038/s41380-021-01297-6. View

14.

Carli G, Caminiti S, Sala A, Galbiati A, Pilotto A, Ferini-Strambi L . Impaired metabolic brain networks associated with neurotransmission systems in the α-synuclein spectrum. Parkinsonism Relat Disord. 2020; 81:113-122. DOI: 10.1016/j.parkreldis.2020.10.036. View

15.

Choudhary M, Kumar A, Tripathi M, Bhatia T, Shivakumar V, Beniwal R . F-18 fluorodeoxyglucose positron emission tomography study of impaired emotion processing in first episode schizophrenia. Schizophr Res. 2015; 162(1-3):103-7. PMC: 4339502. DOI: 10.1016/j.schres.2015.01.028. View

16.

Li R, Lyu H, Liu F, Lian N, Wu R, Zhao J . Altered functional connectivity strength and its correlations with cognitive function in subjects with ultra-high risk for psychosis at rest. CNS Neurosci Ther. 2018; 24(12):1140-1148. PMC: 6489739. DOI: 10.1111/cns.12865. View

17.

Del Fabro L, Schmidt A, Fortea L, Delvecchio G, DAgostino A, Radua J . Functional brain network dysfunctions in subjects at high-risk for psychosis: A meta-analysis of resting-state functional connectivity. Neurosci Biobehav Rev. 2021; 128:90-101. DOI: 10.1016/j.neubiorev.2021.06.020. View

18.

Li T, Wang Q, Zhang J, Rolls E, Yang W, Palaniyappan L . Brain-Wide Analysis of Functional Connectivity in First-Episode and Chronic Stages of Schizophrenia. Schizophr Bull. 2016; 43(2):436-448. PMC: 5605268. DOI: 10.1093/schbul/sbw099. View

19.

Blazer A, Chengappa K, Foran W, Parr A, Kahn C, Luna B . Changes in corticostriatal connectivity and striatal tissue iron associated with efficacy of clozapine for treatment‑resistant schizophrenia. Psychopharmacology (Berl). 2022; 239(8):2503-2514. PMC: 9013738. DOI: 10.1007/s00213-022-06138-0. View

20.

Breier A, Su T, Saunders R, Carson R, Kolachana B, de Bartolomeis A . Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A. 1997; 94(6):2569-74. PMC: 20129. DOI: 10.1073/pnas.94.6.2569. View